OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Key facts

Sponsor

Menzies Institute for Medical Research

Principal Investigator

Peter A Dargaville, MD, MD

Menzies Institute of Medical Research, University of Tasmania

Intervention

Minimally invasive surfactant therapy(device)

Enrollment

486 enrolled

Eligibility

All sexes

Timeline

2011 – 2022

Study locations (16)

• Yale-New Haven Children's Hospital, New Haven, Connecticut, United States
• Kapi'olani Medical Center for Women and Children, Honolulu, Hawaii, United States
• NorthShore Health University HealthSystem Evanston Hospital, Evanston, Illinois, United States
• Cooper University Hospital, Camden, New Jersey, United States
• West Virginia University Hospital, Morgantown, West Virginia, United States
• Royal Hobart Hospital, Hobart, Tasmania, Australia
• Royal Womens Hospital, Melbourne, Victoria, Australia
• Mercy Hospital for Women, Melbourne, Victoria, Australia
• Monash Medical Centre, Melbourne, Victoria, Australia
• Bnai Zion Medical Center, Haifa, Israel
• Ziv Medical Center, Safed, Israel
• Auckland City Hospital, Auckland, New Zealand
• Middlemore Hospital, Auckland, New Zealand
• University Medical Center, Ljubljana, Zaloska, Ljubljana, Slovenia
• Uludag University Hospital, Görükle, Bursa, Turkey (Türkiye)
• +1 more locations on ClinicalTrials.gov

Collaborators

Royal Hobart Hospital · Royal Women's Hospital, Melbourne, Australia · Endeavor Health · Monash Medical Centre · Mercy Hospital for Women, Australia · Auckland City Hospital · Middlemore Hospital, New Zealand · Zekai Tahir Burak Women's Health Research and Education Hospital · Kapiolani Medical Center For Women & Children · The Cooper Health System · Yale University · West Virginia University Hospital · Uludag University · Ziv Medical Center · Bnai Zion Medical Center · University Medical Centre Ljubljana · Dunedin Hospital · Kanuni Sultan Suleyman Training and Research Hospital · University Medical Center Groningen · University of Southern California

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06373289
  Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
  University of Alabama at Birmingham
• RECRUITINGNCT07109791
  National Surveillance and Prevention of Neonatal VAP
  University of Alberta
• RECRUITINGPHASE2NCT07561125
  Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
  International Peace Maternity and Child Health Hospital
• RECRUITINGPHASE2NCT06915441
  Lipid Infusions to Optimize Nutrition Trial
  The University of Texas Health Science Center, Houston
• RECRUITINGPHASE1, PHASE2NCT07101640
  PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
  Duke University
• RECRUITINGNCT07273643
  Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality
  University Hospital, Montpellier
• RECRUITINGEARLY PHASE1NCT07120971
  Metformin for Premature Infants With Bronchopulmonary Dysplasia
  Medical College of Wisconsin
• RECRUITINGPHASE1NCT06589245
  Inhaled Ciclesonide Study in Preterm Infants
  Venkatesh Sampath

See all trials for Bronchopulmonary dysplasia →